MHC class II tetramers engineered for enhanced binding to CD4 improve detection of antigen-specific T cells.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33941928.
- Also identified by DOI 10.1038/s41587-021-00893-9 and PMC identifier 10666075.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The ability to identify T cells that recognize specific peptide antigens bound to major histocompatibility complex (MHC) molecules has enabled enumeration and molecular characterization of the lymphocytes responsible for cell-mediated immunity. Fluorophore-labeled peptide:MHC class I (p:MHCI) tetramers are well-established reagents for identifying antigen-specific CD8<sup>+</sup> T cells by flow cytometry, but efforts to extend the approach to CD4<sup>+</sup> T cells have been less successful, perhaps owing to lower binding strength between CD4 and MHC class II (MHCII) molecules. Here we show that p:MHCII tetramers engineered by directed evolution for enhanced CD4 binding outperform conventional tetramers for the detection of cognate T cells. Using the engineered tetramers, we identified about twice as many antigen-specific CD4<sup>+</sup> T cells in mice immunized against multiple peptides than when using traditional tetramers. CD4 affinity-enhanced p:MHCII tetramers, therefore, allow direct sampling of antigen-specific CD4<sup>+</sup> T cells that cannot be accessed with conventional p:MHCII tetramer technology. These new reagents could provide a deeper understanding of the T cell repertoire.
Medical subject headings
- CD4-Positive T-Lymphocytes
- Fluorescent Dyes
- Histocompatibility Antigens Class II